Viewing Study NCT02693093


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT02693093
Status: COMPLETED
Last Update Posted: 2022-12-16
First Post: 2016-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Sponsor: Kangen Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module